Start:
January 1, 2007
End:
January 2027
Enrollment:
1000
This study will examine the usefulness of various diagnostic tests for Alzheimer's disease, mild cognitive impairment, and other neurodegenerative disease. The study also aims to assess changes in biological, lifestyle, and cognitive assessments collected from individuals over time. The researchers will collect test information from participants either once in a single study visit or if the participant chooses, multiple times over several years. Participants will complete cognitive testing, lifestyle questionnaires, and provide blood and/or spinal fluid (optional) samples for biochemical and genetic testing. Test results will not be shared with participants, but the information will help improve diagnostic tools. Blood and spinal fluid samples will be also be stored in a specimen bank, without any information that would identify the participant, to be available to other researchers.
Minimum Age: 45 Years
Maximum Age: N/A
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
District of Columbia | |
---|---|
Georgetown University Memory Disorders Program
Washington,
DC
20057
Recruiting
Kelly McCann |
Lead: Georgetown University
Source: ClinicalTrials.gov ID: NCT03702907
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health